Selected Key Players:
Abcam Inc.
Agilent Technologies Inc.
Applied StemCell Inc.
Caribou Biosciences Inc.
Cellecta Inc.
CRISPR Therapeutics AG
Editas Medicine Inc.
GeneCopoeia Inc.
GeneScript Biotech Corporation
Horizon Discovery Group PLC
Integrated DNA Technologies Inc.
Intellia Therapeutics Inc.
Lonza Group Ltd.
Merck KGaA
New England Biolabs Inc.
Origene Technologies Inc.
Rockland Immunochemicals Inc.
Synthego Corporation
System Biosciences LLC
Takara Bio Inc.
Thermo Fisher Scientific Inc.
ToolGen Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)